Growth Metrics

Acadia Healthcare Company (ACHC) Cash from Financing Activities (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Cash from Financing Activities for 16 consecutive years, with $193.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 139.24% to $193.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $481.3 million, a 17.45% decrease, with the full-year FY2025 number at $481.3 million, down 17.45% from a year prior.
  • Cash from Financing Activities was $193.3 million for Q4 2025 at Acadia Healthcare Company, up from $43.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $483.1 million in Q1 2024 to a low of -$1.6 billion in Q1 2021.
  • A 5-year average of -$37.3 million and a median of -$8.5 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 22012.7% in 2021; the steepest drop was 12167.23% in 2021.
  • Acadia Healthcare Company's Cash from Financing Activities stood at $69.7 million in 2021, then tumbled by 124.83% to -$17.3 million in 2022, then skyrocketed by 67.31% to -$5.7 million in 2023, then skyrocketed by 1528.88% to $80.8 million in 2024, then skyrocketed by 139.24% to $193.3 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Cash from Financing Activities are $193.3 million (Q4 2025), $43.8 million (Q3 2025), and $57.5 million (Q2 2025).